8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Cancer & Tumors418 citations

Qin F, Cao H, Feng C, Zhu T, Zhu B, Zhang J, Tong J, Pei H

Bioeffects Seen

Authors not listed · 2021

Share:

Advanced molecular profiling techniques used in cancer research should be applied to EMF exposure studies.

Plain English Summary

Summary written for general audiences

Researchers conducted a comprehensive molecular analysis of 140 pancreatic cancers using advanced protein and genetic sequencing techniques. This study created a detailed molecular map of pancreatic ductal adenocarcinoma (PDAC), one of the most aggressive cancers. The findings provide a foundation for developing better early detection methods and new treatments for this deadly disease.

Why This Matters

While this study doesn't directly examine EMF exposure, it represents the kind of comprehensive molecular profiling that's desperately needed in EMF health research. The researchers analyzed proteins, DNA modifications, and cellular signaling pathways in pancreatic cancer - the exact type of detailed biological investigation that could reveal how electromagnetic fields influence cancer development at the molecular level. What this means for you: we need similar proteogenomic studies examining how EMF exposure affects cellular proteins and signaling pathways in healthy tissue, not just after cancer has already developed. The reality is that most EMF research still relies on basic cell viability tests, while cancer research has moved to sophisticated molecular profiling that can detect subtle but important biological changes long before disease appears.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2021). Qin F, Cao H, Feng C, Zhu T, Zhu B, Zhang J, Tong J, Pei H.
Show BibTeX
@article{qin_f_cao_h_feng_c_zhu_t_zhu_b_zhang_j_tong_j_pei_h_ce2977,
  author = {Unknown},
  title = {Qin F, Cao H, Feng C, Zhu T, Zhu B, Zhang J, Tong J, Pei H},
  year = {2021},
  doi = {10.1016/j.cell.2021.08.023},
  
}
DOI: 10.1016/j.cell.2021.08.023PubMed: 34534465

Quick Questions About This Study

Proteogenomic analysis combines protein studies with genetic sequencing to understand how DNA changes affect protein function. In this pancreatic cancer study, researchers examined proteins, their modifications, and genetic alterations simultaneously to create a comprehensive molecular picture of how cancer develops.
Researchers analyzed 216 tissue samples total: 140 pancreatic cancers, 67 normal adjacent tissues, and 9 normal pancreatic ductal tissues. This large sample size allowed for robust comparison between cancerous and healthy tissue at the molecular level.
The study used six different molecular analysis methods: proteomic analysis (proteins), phosphoproteomic analysis (protein modifications), glycoproteomic analysis (sugar-protein attachments), whole-genome sequencing, RNA sequencing, and microRNA sequencing to create a complete molecular profile.
Tumor cellularity verification ensures that tissue samples contain enough actual cancer cells versus normal cells for accurate analysis. Researchers used both molecular features and pathological examination to confirm samples had sufficient tumor content for reliable downstream molecular analysis.
This comprehensive molecular characterization creates a valuable reference database for the research community. It provides detailed molecular signatures of pancreatic cancer that can guide development of early detection methods and identification of new therapeutic targets for this aggressive disease.